← Open Payments lookup

NATHAN PLATT: Open Payments

NPI 1003450057 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$853 in 42 payments from 7 companies in 2025. Trend: 2023 $561 · 2024 $474 · 2025 $853

Food & beverage: $853
CompanyPaymentsAmount
Lilly USA, LLC12$210
Novo Nordisk Inc11$201
ABBVIE INC.7$178
AstraZeneca Pharmaceuticals LP6$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Eisai Inc.2$55
GlaxoSmithKline, LLC.1$35

Products named: VRAYLAR, MOUNJARO, Wegovy, CAPLYTA, Leqembi, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA.

Industry payments across PA — which companies pay providers there.